These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 9243573)

  • 41. A national household survey of drug misuse in Britain: a decade of development.
    Ramsay M; Percy A
    Addiction; 1997 Aug; 92(8):931-7. PubMed ID: 9376776
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Aggregate and individual replication probability within an explicit model of the research process.
    Miller J; Schwarz W
    Psychol Methods; 2011 Sep; 16(3):337-60. PubMed ID: 21534683
    [TBL] [Abstract][Full Text] [Related]  

  • 43. The validity of a province-wide student drug use survey: lessons in design.
    Poulin C; MacNeil P; Mitic W
    Can J Public Health; 1993; 84(4):259-64. PubMed ID: 8221500
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Reliability and validity of adolescent self-reported drug use in a family-based study: a methodological report.
    Needle R; McCubbin H; Lorence J; Hochhauser M
    Int J Addict; 1983 Oct; 18(7):901-12. PubMed ID: 6605944
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Diseases having two classes of severity: estimation of the proportions of each manifestation by maximum likelihood.
    Bonaïti C; Demenais F
    Biometrics; 1980 Sep; 36(3):447-60. PubMed ID: 7213908
    [TBL] [Abstract][Full Text] [Related]  

  • 46. An Online Survey for Pharmacoepidemiological Investigation (Survey of Non-Medical Use of Prescription Drugs Program): Validation Study.
    Black JC; Rockhill K; Forber A; Amioka E; May KP; Haynes CM; Dasgupta N; Dart RC
    J Med Internet Res; 2019 Oct; 21(10):e15830. PubMed ID: 31654568
    [TBL] [Abstract][Full Text] [Related]  

  • 47. What is the prevalence of drug use in the general population? Simulating underreported and unknown use for more accurate national estimates.
    Levy NS; Palamar JJ; Mooney SJ; Cleland CM; Keyes KM
    Ann Epidemiol; 2022 Apr; 68():45-53. PubMed ID: 34990827
    [TBL] [Abstract][Full Text] [Related]  

  • 48. An ad hoc method for dual adjusting for measurement errors and nonresponse bias for estimating prevalence in survey data: Application to Iranian mental health survey on any illicit drug use.
    Khalagi K; Mansournia MA; Motevalian SA; Nourijelyani K; Rahimi-Movaghar A; Bakhtiyari M
    Stat Methods Med Res; 2018 Oct; 27(10):3062-3076. PubMed ID: 29298600
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Self-report methods of estimating drug use: Meeting current challenges to validity.
    NIDA Res Monogr; 1985; 57():1-174. PubMed ID: 3929107
    [No Abstract]   [Full Text] [Related]  

  • 50. Specifying the correlation structure in inverse-probability- weighting estimation for repeated measures.
    Tchetgen Tchetgen EJ; Glymour MM; Weuve J; Robins J
    Epidemiology; 2012 Jul; 23(4):644-6. PubMed ID: 22659551
    [No Abstract]   [Full Text] [Related]  

  • 51. Survey estimates of drug-use trends in urban communities: general principles and cautionary examples.
    Beveridge AA; Kadushin C; Saxe L; Rindskopf D; Livert D
    Subst Use Misuse; 2000; 35(6-8):891-923. PubMed ID: 10847216
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Prediction models in small area estimation: discussion.
    Nisselson H
    NIDA Res Monogr; 1979 Feb; (24):88-97. PubMed ID: 114857
    [No Abstract]   [Full Text] [Related]  

  • 53. Reporting bias and self-reported drug use.
    Macleod J; Hickman M; Smith GD
    Addiction; 2005 Apr; 100(4):562-3. PubMed ID: 15784073
    [No Abstract]   [Full Text] [Related]  

  • 54. Bias and heteroscedastic memory error in self-reported health behavior: an investigation using covariance structure analysis.
    Kupek E
    BMC Med Res Methodol; 2002 Nov; 2():14. PubMed ID: 12435276
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Effects of interview mode on bias in survey measurements of drug use: do respondent characteristics make a difference?
    Rogers SM; Miller HG; Turner CF
    Subst Use Misuse; 1998 Aug; 33(10):2179-200. PubMed ID: 9744846
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Monitoring trends in drug use: strategies for the 21st century.
    Turner CF; Miller HG
    Subst Use Misuse; 1997 Dec; 32(14):2093-103. PubMed ID: 9440154
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [The problem of careless respondents in surveys].
    Merckelbach H; Giesbrecht T; Jelicic M; Smeets T
    Tijdschr Psychiatr; 2010; 52(9):663-9. PubMed ID: 20862650
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Overview of validity, quality control and measurement error issues in nutritional epidemiology.
    Kohlmeier L
    Eur J Clin Nutr; 1993 Oct; 47 Suppl 2():S1-5. PubMed ID: 8262012
    [No Abstract]   [Full Text] [Related]  

  • 59. First record: a methodological approach to counter sampling bias.
    Johnson LC; Beaton R; Murphy SA
    Psychol Rep; 2004 Oct; 95(2):391-2. PubMed ID: 15587198
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Measuring interstate variations in drug problems.
    McAuliffe WE; LaBrie R; Lomuto N; Betjemann R; Fournier E
    Drug Alcohol Depend; 1999 Jan; 53(2):125-45. PubMed ID: 10080039
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.